Medically Reviewed by
Dr. Akansha is a board-certified English-educated urologist and is a member of the American Urology Association (AUA) and the American Urological Association (AUA). She has a B. S. in Biology and a D. V. in Biochemistry.
Propecia
Propecia inhibits the growth of the prostate gland. In the absence of an enzyme inhibitor, the prostate gland produces a protein called a 5-alpha-reductase. 5-alpha reductase converts testosterone to dihydrotestosterone (DHT). DHT binds to the 5-alpha-reductase sites within the prostate gland, which blocks the conversion of testosterone to DHT. This leads to the formation of DHT, which leads to an increase in prostate gland size and decreased urinary flow. By blocking the action of the 5-alpha-reductase enzyme, Propecia helps to reduce the size of the prostate gland and prevent prostate cancer. In fact, Propecia can significantly lower prostate cancer risk by reducing the size of the prostate gland. It also has been shown to reduce the risk of prostate cancer by about 40% when used in combination with other drugs.
Propecia can interact with other drugs and can have side effects. In some cases, this can lead to severe allergic reactions. The following is a list of drugs that can cause severe allergic reactions to Propecia:
Cisapride: This is a drug commonly used to treat depression and anxiety disorders. It can cause anaphylaxis. The list of drugs that can cause severe allergic reactions to Propecia include:
Lithium: This drug can cause drowsiness and increase the risk of suicidal thoughts. It can also cause a rare but potentially life-threatening condition known as manic depression. This condition can be fatal if left untreated.
Warfarin: This drug can be used to prevent blood clots. It can cause a blood clot in the lungs or blood vessels. It can also cause serious heart rhythm problems and stroke.
Risperidone: This drug can cause a severe allergic reaction. It can also cause a rare but potentially life-threatening condition known as anaphylaxis.
Phenytoin: This drug can cause a rare but potentially life-threatening condition known as a porphyria.
Sulfasalazine: This drug can cause a rare but potentially life-threatening condition known as a sulfa allergy. It can also cause a severe allergic reaction.
Zolmitriptan
This study used a combination of data from two different clinical trials to assess the efficacy of Propecia (finasteride) for treatment of benign prostatic hyperplasia (BPH). In both trials, the results showed that Propecia was more effective than Proscar (5 mg) in reducing the risk of symptomatic and asymptomatic prostate cancer in men with BPH. In fact, Propecia reduced the incidence of prostate cancer by approximately 30 percent in men with BPH, compared to placebo (3.3 percent).
Figure 1. Propecia versus Proscar for the treatment of BPH.
Figure 2
Figure 3
The study design of the studies was designed to provide more information about the effectiveness of Finasteride (5 mg) for the treatment of BPH. The study design of the studies included a total of six phases: a 1-year, randomized, double-blind, placebo-controlled, open-label clinical trial in men with BPH, and the 12-month, randomized, double-blind, placebo-controlled, open-label, clinical trial in men with BPH.
The primary objective of the study was to assess the safety and tolerability of finasteride in men with BPH and to determine the clinical benefit of this treatment in men with BPH.
The secondary objectives included the assessment of the effect of finasteride in men with BPH, and the evaluation of the response and tolerability of finasteride in men with BPH.
The primary outcomes of the study were the incidence of prostate-related events, the percentage of men with a reduction of the risk of prostate-related event, and the rates of treatment-related adverse events (heart attack, stroke, and genital pain).
The secondary outcomes were the incidence of adverse events related to prostate cancer, the percentage of men with a reduction of the risk of prostate-related event, and the rates of treatment-related adverse events (heart attack, stroke, and genital pain).
The primary endpoints were the incidence of symptomatic prostate cancer, the incidence of benign prostatic hypertrophy (BPH), the percentage of men with a reduction of the risk of symptomatic BPH, and the overall incidence of prostate cancer. The secondary endpoints were the rate of treatment-related adverse events (heart attack, stroke, genital pain, and prostate cancer), the rate of treatment-related events (heart attack, stroke, genital pain, and prostate cancer), the percentage of men with a reduction of the risk of prostate-related event, and the overall incidence of prostate cancer.
The study population included patients with a risk for prostate cancer of <50% and a risk for benign prostatic hypertrophy of at least 50%.
Table 1Population characteristics of patients with and without prostate cancer.
Table 1. Population characteristics of patients with prostate cancer.
Table 2Frequency of prostate cancer incidence, treatment-related adverse events (heart attack, stroke, and genital pain), and the overall incidence of prostate cancer (%).
Table 3Frequency of treatment-related adverse events (heart attack, stroke, and genital pain).
Table 4Frequency of treatment-related events (heart attack, stroke, and genital pain).
Table 5Frequency of treatment-related adverse events (heart attack, stroke, genital pain).
Table 6Frequency of treatment-related events (heart attack, stroke, genital pain).
Table 7Frequency of treatment-related events (stroke, genital pain, prostate cancer, and treatment-related events).
Table 8
Table 9
Table 10Frequency of treatment-related adverse events (stroke, genital pain, prostate cancer, and treatment-related events).
Table 11
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
StomachhealthyThis is aaring name;
Healthylife is aursions supplier of Propecia, an extract from the marine fasciity and hair follicles of the finkelian marmificantly more efficient than the traditional traditional extract. Propecia is a hair loss treatment for male pattern hair loss. Propecia is also a treatment for male pattern hair loss. It works by blocking the production of a substance in the body called dihydrotestosterone (DHT), a hormone that contributes to hair loss. Propecia also works by blocking the activity of an enzyme called type II 5-alpha reductase, which is responsible for converting testosterone to DHT.
Healthylife Pharmacy is not responsible for any side effects that may be experienced by you when you take Stomachhealthy. If you have any questions about your medicines, please contact Healthylife Pharmacy.
Stomach HealthyHealthylife is a independent pharmacy that guarantees each item you buy is fully reviewed by your doctor. This ensures that the parcel arrives at your doorstep with the confidence that it will be delivered in comfort and hygiene standards. Ordering and ordering from Healthylife is breeze. Simply select the item you want and enjoy the convenience of ordering over the counter medicines online. Healthylife Pharmacy is the best choice for you if you're looking for an extract from the marine fasciity and hair follicles of the finkelian marmingly more efficient than the traditional traditional extract. Healthylife Pharmacy is the best choice for you if you are looking for an extract from the marine fasciity and hair follicles of the finkelian marmingly more efficient than the traditional traditional extract.
WASHINGTON — The Department of Health and Human Services released a final guidance document on the use of the popular hair loss drug finasteride for hair loss treatment in the United States.
The federal government will take up the first update on the use of finasteride to cover the first time in three years for the sale of the drug, but it's not clear how long that will be.
The guidance is part of a larger effort to update the U. S. Food and Drug Administration for prescribing finasteride in the treatment of male pattern baldness in women and men.
The agency also issued an update on the use of the drug in the treatment of benign prostatic hyperplasia (BPH) in men and in women, with an update on the use of finasteride in men with an enlarged prostate.
The agency also issued a letter to Health Canada to clarify that finasteride is only used in men and that it is not approved for use in women and that women should not use the drug.
The drug's approved label, which was recently released in Canada, does not mention finasteride or any other medications for BPH. It also does not list the drugs for other conditions or diseases, including those that affect the hair growth process.
Under the guidance, the agency will also review the use of finasteride in the treatment of benign prostatic hyperplasia in men and in women.
The drug was originally approved for sale in the United States in 1998.
The drug, which is sold under the brand name Propecia, is the only drug to be approved by the Food and Drug Administration for the treatment of male pattern baldness.
The drug has been shown to be effective in patients with a history of hair loss. The FDA has issued a notice for finasteride to be prescribed by the FDA for patients who are already taking finasteride.
The drug's label also does not mention the use of finasteride in men or women.
The agency does not recommend that patients stop taking finasteride because of side effects. However, a few women have asked to stop using the drug.
The FDA has also issued a letter to Health Canada to clarify that finasteride is only approved for use in men and that the drug is not intended for use in women and does not affect the effectiveness of other hair loss medications.
The agency also issued an update on the use of finasteride in men and women.
The agency will also review the use of finasteride in the treatment of benign prostatic hyperplasia (BPH) in men and in women, with an update on the use of finasteride in men with an enlarged prostate.
The agency also will update its guidelines for prescribing finasteride in the treatment of BPH.
The information is being provided to the public only.
Originally Published: October 15, 2013 at 1:00 pm
Originally Published: October 15, 2013 at 3:30 pmThe Department of Health and Human Services is continuing to review the use of the popular hair loss drug finasteride for hair loss treatment in the United States.
Propecia is a medication that contains finasteride 1mg. Finasteride works by inhibiting the 5-alpha reductase enzyme that converts testosterone to dihydrotestosterone (DHT), which is the male sex hormone that is responsible for the male genitals. DHT is found in the body in various forms, including semen, blood, and fat cells. Propecia is used to treat the symptoms of benign prostatic hyperplasia (BPH) or enlarged prostate, as well as male-pattern baldness and male pattern baldness. Propecia is also available in the form of tablets or capsules. Propecia tablets may be used by adults and children from 10 years of age to help men who have a condition that causes symptoms to stop. Propecia is a prescription medication that is used to treat male pattern baldness or enlarged prostate. Propecia tablets contain the active ingredient finasteride 1mg. It works by blocking the enzyme responsible for converting testosterone into DHT.
Propecia works by blocking the enzyme that is responsible for converting testosterone to dihydrotestosterone (DHT), which is the male sex hormone that is responsible for the male genitals.
We have with us superior quality PROPECIA (finasteride) tablets to date. We focus on providing our patients with a simple, pain free treatment that is suitable for our diverse patients.
Our service fee Independent Pharmacy care is provided by a licensed medical professional with specific needs in mind. This help to deal with any unwanted effects will be able to explain any concerns or possible risks prior to commencing the treatment. This is why we will ensure that the treatment is carried out in a way that improves the overall experience. Therefore we work directly with a medical professional from the pharmaceutical industry that can provide you with the most appropriate advice and treatment.
We also have a strict personal preferences policy which means that you will only get to buy our medicines after discussing all your medical conditions with our medical professional. This will ensure that the treatment is suitable for your needs. Therefore we will not be able to send any unwanted medication out of the us because it is not approved.
You can always check the patient information leaflet or the box below or read the instructions that come with the pack prior to commencing the treatment.
us and download the latest privacy information, including our data protection policy.
Stade de France Pharmacy